Sulaiman Al Habib H1 2023 profit rises 24% to SAR 976.2 mln; Q2 at SAR 487 mln

06/08/2023 Argaam Exclusive

View other reports

Dr. Sulaiman Al Habib Medical Services Group posted a 24% profit jump in H1 2023 to SAR 976.2 million, compared to SAR 788.6 million in H1 2022, thanks to a 14.34% rise year-on-year (YoY) in revenue to SAR 4.57 billion. This was driven by the growth in the hospital and pharmacy segments, due to increased number of patients and inpatients occupancy, which in turn boosted the pharmacy segment sales.

Financials (M)

Item	6m 2022	6m 2023	Change‬
Revenues	4,004.87	4,579.14	14.3 %
Gross Income	1,329.44	1,558.47	17.2 %
Operating Income	836.84	1,009.38	20.6 %
Net Income	788.64	976.24	23.8 %
Average Shares	350.00	350.00	-
EPS (Riyals)	2.25	2.79	23.8 %

Earnings before interest, taxes, depreciation and amortization (EBITDA) increased 18.26% YoY to SAR 1.23 billion. Net profit margins expanded by 1.63% YoY to 21.32% from 19.69% in H1 2022.

In Q2 2023, the net profit grew 22% to SAR 487 million from SAR 398.13 million in the prior-year period. Revenue grew by 12.82% YoY to SAR 2.27 billion on continued growth in operating segments. EBITDA jumped 16.88% YoY to SAR 615.61 million. Net profit margins also rose to 21.34% from 19.77% in Q2 2022.

Current Quarter Comparison (M)

Compared With The

Item	Q2 2022	Q2 2023	Change‬
Revenues	2,014.01	2,272.27	12.8 %
Gross Income	670.88	774.83	15.5 %
Operating Income	414.75	498.81	20.3 %
Net Income	398.13	486.97	22.3 %
Average Shares	350.00	350.00	-
EPS (Riyals)	1.14	1.39	22.3 %

Item	Q1 2023	Q2 2023	Change‬
Revenues	2,306.88	2,272.27	(1.5 %)
Gross Income	783.64	774.83	(1.1 %)
Operating Income	510.57	498.81	(2.3 %)
Net Income	489.27	486.97	(0.5 %)
Average Shares	350.00	350.00	-
EPS (Riyals)	1.40	1.39	(0.5 %)

The net earnings edged down 0.5% from SAR 489.27 million in Q1 2023, as revenue decreased by 1.50% due to seasonal factors in the second quarter of the year.

Shareholders’ equity, after minority interest, stood at SAR 6.19 billion by the end of the six-month period, up from SAR 5.59 billion a year earlier.

View more financial results

Kindly, you can view the full report by subscribing to the

The report contains the details of the financial statements, The most important financial indicators, Historical information, Charts, and Forecasts of experts.

Twitter

Facebook

Linked in

Comments {{getCommentCount()}}

Be the first to comment

رد{{comment.DisplayName}} على {{getCommenterName(comment.ParentThreadID)}}

Sorry: the validity period has ended to comment on this news

Opinions expressed in the comments section do not reflect the views of Argaam. Abusive comments of any kind will be removed. Political or religious commentary will not be tolerated.

×